FILING ANALYSIS · WEDNESDAY, OCTOBER 28
BIOGEN INC. BIIB — 8-K: Results of Operations and Financial Condition
positive
Biogen's Q3 revenue grew 11% year-over-year to $2.8 billion, driven by a 49% increase in Growth Portfolio revenue, and the company raised the lower end of its full-year Non-GAAP diluted EPS guidance to $12.20-$13.00
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →